Drug Study
Drug Study
Magallona
Initials:
Room #: 408 Sex: F Dx: Fracture, open II, complete communutes, m/3, femur L,
Fracture, closed, compete, lateral epicopale, humerus R
Sepsis, anemia
cloxacillin Tegopen Pharmacologic: By binding to Staphylococcal EENT: laryngeal 1. Perform skin testing before administration.
syrup penicillinase- specific infections edema 2. Watch for seizures; notify physician
resistantpenicillins penicillin- Derm: urticaria, immediately if patient develops or
Route: PO Therapeutic: anti- binding skin rash, increases seizure activity.
Dose: 5ml infectives proteins exfoliative 3. Side rails up
Frequency: (PBPs) located dermarirs, rash 4. Monitor signs of adverse reactions such as,
TID x 1 inside the GI: GI allergic reactions and anaphylaxis,
week bacterial cell disturbances, including pulmonary symptoms or skin
8AM – 2PM wall, vomiting, nausea, reactions. Notify physician or nursing staff
cloxacillin epigastric distress, immediately if these reactions occur.
inhibits the diarrhea, 5. Monitor CBC with differential, urinalysis,
third and last flatulence BUN, serum creatinine, and liver enzymes.
stage of GU: interstitial 6. Finish all medications: do not skip doses
bacterial cell nephritis and 7. Document
wall synthesis. vasculitis
Cell lysis is HEMA:
then mediated eosinophilia,
by bacterial agranulocytosis,
cell wall anemia,
autolytic thrombocytopeni
enzymes such a
as autolysins; Other;
it is possible hypersensitivity
that cloxacillin
interferes with
an autolysin
inhibitor.
ibuprofen Advil Pharmacologic: Reversibly For pain CNS: headache, 1. Monitor signs of allergic reaction
antirheumatic, inhibits COX-1 dizziness, 2. Observe 12 rights of medication
Route: PO analgesics, and COX-2 drowsiness, 3. Monitor for therapeutic effectiveness
Dose: antipyretic enzymes, psychic 4. Document
200mg/5ml Therapeutic: NSAID resulting in disturbances
Frequency: decreased EENT: amblyopia,
q6h as formation of blurred vision,
needed prostaglandin tinnitus
receptors CV: arrhythmias,
edema
GI: GI bleeding,
hepatits,
constipation,
dyspepsia,
nausea, vomiting,
abdominal
discomfort
GU: cystitis,
hematuria, renal
failure
DERM: exfoliative
dermititas,
stevens-johnson
syndrome, toxic
epidermal
necrolysis, rashes
HEMAT: blood
dyscrasias,
prolonged
bleeding
Others;
anaphylaxis
mupirocin Bactroban Pharmacologic: Inhibits Surgical 1. Assess skin for type, extent of lesions.
topical antibiotic bacterial prophylaxis to 2. Monitor healing of skin lesions. Stop
Route: Therapeutic: protein, RNA prevent wound application if skin reactions occur. Notify
Topical antibacterial synthesis, less infections. physician.
Frequency: effective on 3. For external use only
until DNA synthesis 4. Avoid contact with eyes
wounds 5. Document findings.
heal